These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34430392)

  • 21. Immunohistochemical Analysis of the Metabolic Phenotype of Adrenal Cortical Carcinoma.
    Duan K; Gucer H; Kefeli M; Asa SL; Winer DA; Mete O
    Endocr Pathol; 2020 Sep; 31(3):231-238. PubMed ID: 32367334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The utility of SDHB and FH immunohistochemistry in patients evaluated for hereditary paraganglioma-pheochromocytoma syndromes.
    Udager AM; Magers MJ; Goerke DM; Vinco ML; Siddiqui J; Cao X; Lucas DR; Myers JL; Chinnaiyan AM; McHugh JB; Giordano TJ; Else T; Mehra R
    Hum Pathol; 2018 Jan; 71():47-54. PubMed ID: 29079178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA Expression Profiling in Adrenal Myelolipoma.
    Decmann A; Perge P; Nyíro G; Darvasi O; Likó I; Borka K; Micsik T; Tóth Z; Bancos I; Pezzani R; Iacobone M; Patócs A; Igaz P
    J Clin Endocrinol Metab; 2018 Sep; 103(9):3522-3530. PubMed ID: 29982598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AQP2 as a diagnostic immunohistochemical marker for pheochromocytoma and/or paraganglioma.
    Niu D; Bai Y; Yao Q; Zhou L; Huang X; Zhao C
    Gland Surg; 2020 Apr; 9(2):200-208. PubMed ID: 32420243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High diagnostic and prognostic value of steroidogenic factor-1 expression in adrenal tumors.
    Sbiera S; Schmull S; Assie G; Voelker HU; Kraus L; Beyer M; Ragazzon B; Beuschlein F; Willenberg HS; Hahner S; Saeger W; Bertherat J; Allolio B; Fassnacht M
    J Clin Endocrinol Metab; 2010 Oct; 95(10):E161-71. PubMed ID: 20660055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of progesterone and estradiol receptors in normal adrenal cortex, adrenocortical tumors, and primary pigmented nodular adrenocortical disease.
    de Cremoux P; Rosenberg D; Goussard J; Brémont-Weil C; Tissier F; Tran-Perennou C; Groussin L; Bertagna X; Bertherat J; Raffin-Sanson ML
    Endocr Relat Cancer; 2008 Jun; 15(2):465-74. PubMed ID: 18508999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. USP10 Expression in Normal Adrenal Gland and Various Adrenal Tumors.
    Zeng Z; Zhou Z; Zhan N; Yuan J; Ye B; Gu L; Wang J; Jian Z; Xiong X
    Endocr Pathol; 2015 Dec; 26(4):302-8. PubMed ID: 26555087
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of miR-101 in pheochromocytoma patients with SDHD mutation.
    Zong L; Meng L; Shi R
    Int J Clin Exp Pathol; 2015; 8(2):1545-54. PubMed ID: 25973039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosis.
    Comino-Méndez I; de Cubas AA; Bernal C; Álvarez-Escolá C; Sánchez-Malo C; Ramírez-Tortosa CL; Pedrinaci S; Rapizzi E; Ercolino T; Bernini G; Bacca A; Letón R; Pita G; Alonso MR; Leandro-García LJ; Gómez-Graña A; Inglada-Pérez L; Mancikova V; Rodríguez-Antona C; Mannelli M; Robledo M; Cascón A
    Hum Mol Genet; 2013 Jun; 22(11):2169-76. PubMed ID: 23418310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytochrome c oxidase subunit 4 isoform 2-knockout mice show reduced enzyme activity, airway hyporeactivity, and lung pathology.
    Hüttemann M; Lee I; Gao X; Pecina P; Pecinova A; Liu J; Aras S; Sommer N; Sanderson TH; Tost M; Neff F; Aguilar-Pimentel JA; Becker L; Naton B; Rathkolb B; Rozman J; Favor J; Hans W; Prehn C; Puk O; Schrewe A; Sun M; Höfler H; Adamski J; Bekeredjian R; Graw J; Adler T; Busch DH; Klingenspor M; Klopstock T; Ollert M; Wolf E; Fuchs H; Gailus-Durner V; Hrabě de Angelis M; Weissmann N; Doan JW; Bassett DJ; Grossman LI
    FASEB J; 2012 Sep; 26(9):3916-30. PubMed ID: 22730437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostate-Specific Membrane Antigen Is a Potential Antiangiogenic Target in Adrenocortical Carcinoma.
    Crowley MJ; Scognamiglio T; Liu YF; Kleiman DA; Beninato T; Aronova A; Liu H; Jhanwar YS; Molina A; Tagawa ST; Bander NH; Zarnegar R; Elemento O; Fahey TJ
    J Clin Endocrinol Metab; 2016 Mar; 101(3):981-7. PubMed ID: 26771706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigation of N-cadherin/β-catenin expression in adrenocortical tumors.
    Rubin B; Regazzo D; Redaelli M; Mucignat C; Citton M; Iacobone M; Scaroni C; Betterle C; Mantero F; Fassina A; Pezzani R; Boscaro M
    Tumour Biol; 2016 Oct; 37(10):13545-13555. PubMed ID: 27468715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential heparanase-1 expression in malignant and benign pheochromocytomas.
    Quiros RM; Kim AW; Maxhimer J; Gattuso P; Xu X; Prinz RA
    J Surg Res; 2002 Nov; 108(1):44-50. PubMed ID: 12443714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinicopathologic features and expression of epidermal growth factor receptor and vascular endothelial growth factor in adrenocortical tumors].
    Wang CP; Zhang J; Gao J; Liu PP; Wu SF; Zeng X; Liang ZY
    Zhonghua Bing Li Xue Za Zhi; 2012 Oct; 41(10):686-90. PubMed ID: 23302311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors.
    Arlt W; Biehl M; Taylor AE; Hahner S; Libé R; Hughes BA; Schneider P; Smith DJ; Stiekema H; Krone N; Porfiri E; Opocher G; Bertherat J; Mantero F; Allolio B; Terzolo M; Nightingale P; Shackleton CH; Bertagna X; Fassnacht M; Stewart PM
    J Clin Endocrinol Metab; 2011 Dec; 96(12):3775-84. PubMed ID: 21917861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation between CT features of adrenocortical and adrenal medullary tumors and expression of miR-96 in serum.
    Xu Y; Wang Z; Bi Y; Duan Z; Yue X
    Oncol Lett; 2018 Aug; 16(2):2053-2057. PubMed ID: 30008900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytochrome
    Pajuelo Reguera D; Čunátová K; Vrbacký M; Pecinová A; Houštěk J; Mráček T; Pecina P
    Cells; 2020 Feb; 9(2):. PubMed ID: 32075102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exocrine pancreatic insufficiency, dyserythropoeitic anemia, and calvarial hyperostosis are caused by a mutation in the COX4I2 gene.
    Shteyer E; Saada A; Shaag A; Al-Hijawi FA; Kidess R; Revel-Vilk S; Elpeleg O
    Am J Hum Genet; 2009 Mar; 84(3):412-7. PubMed ID: 19268275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of endothelial PAS domain protein 1 and hypoxia inducible factor 1alpha on vascular endothelial growth factor expression in human pancreatic carcinoma.
    Zhu DM; Li DC; Zhang ZX; Zhang XY
    Chin Med J (Engl); 2008 Nov; 121(22):2258-64. PubMed ID: 19080330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survivin in adrenocortical tumors - pathophysiological implications and therapeutic potential.
    Sbiera S; Kroiss M; Thamm T; Beyer M; Majidi F; Kuehner D; Wobser M; Becker JC; Adam P; Ronchi C; Allolio B; Fassnacht M
    Horm Metab Res; 2013 Feb; 45(2):137-46. PubMed ID: 23143666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.